Implementation and effect of intensified case finding on diagnosis of tuberculosis in a large urban HIV clinic in Uganda: a retrospective cohort study.

BMC Public Health

Yukari C Manabe¹  Joep Lange⁶  Andy Hoepelman⁵  Miriam Schwarz³  Elena Byhoff²  Frank van Leth⁶  Esther Nasuuna⁴  Sabine Hermans⁵ 

[1] Department of Medicine, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD, USA;University of Pennsylvania School of Medicine, Philadelphia, PA, USA;Fogarty International Clinical Research Scholars Program, Washington, WA, USA;Infectious Diseases Institute, Makerere University College of Health Sciences, PO Box 22418, Kampala, Uganda;Department of Internal Medicine and Infectious Diseases, University Medical Center Utrecht, Utrecht, The Netherlands;Department of Global Health, Academic Medical Center, University of Amsterdam, Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands

关键词: Yield;    Costing analysis;    Resource-limited setting;    Implementation research;    HIV/AIDS;    Screening;    Tuberculosis;    Intensified case finding;   

Others  :  1163253
DOI  :  10.1186/1471-2458-12-674

 received in 2012-02-27, accepted in 2012-08-10,  发布年份 2012

【 摘 要 】

Background

Increased detection of tuberculosis (TB) using intensified or active case finding (ICF) is one of the cornerstones of the Stop TB Strategy, and contrasts with passive case finding (PCF) which relies on self-reported symptoms. There is no clear guidance on implementation strategies. We implemented ICF in addition to ongoing PCF in our large urban HIV clinic in July 2010 using a twice-daily announcement screen method by a trained peer educator, asking waiting patients to self-refer to a trained peer supporter for screening of TB symptoms. We sought to determine the associated effect on TB case detection.

Methods

Suspects were investigated by sputum smear, chest X-ray and ultrasound, if indicated. Routinely collected clinical and laboratory data were merged with the ICF register and TB clinic data for patients attending the clinic in 2010. We compared the yield of TB cases (defined as the prevalence of newly diagnosed TB cases in the screened population), the type of TB diagnosed and the total cost per TB case identified (in United States Dollars [USD]) for the period before and after ICF implementation.

Results

Of the 20,456 patients who visited the clinic in 2010, 614 were identified as TB suspects, 220 pre-ICF and 394 post-ICF (229 via PCF and 165 via ICF). The proportion diagnosed with TB dropped from 66% to 48% (60% in suspects identified through PCF and 31% through ICF). During the post-ICF period, TB suspects identified through ICF compared to PCF identification were more likely to be female, older, on ART and to have been enrolled in HIV care for a longer duration. The yield of combined PCF and ICF screening was 1.4% pre-ICF and 1.7% post-ICF with a cost per TB case identified of 12.29 USD and 21.80 USD, respectively.

Conclusions

Implementation of ICF in a large HIV clinic yielded more TB suspects and cases, but substantially increased costs and was unable to capture the majority of TB suspects who were referred for diagnosis by clinicians through PCF. The overall yield of TB cases in a mature HIV clinic was low, although targeted screening of those recently enrolled in care may increase the yield.

【 授权许可】

   
2012 Hermans et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]World Health Organization: Report on global tuberculosis control. Geneva, Switzerland: World Health Organisation; 2011.
• [2]World Health Organization: Interim policy on collaborative TB/HIV activities. Geneva, Switzerland: World Health Organisation; 2004.
• [3]World Health Organization: 3I's meeting report. Geneva, Switzerland: WHO HIV/AIDS and TB Department; 2008.
• [4]Den Boon S, Verver S, Lombard C, Bateman E, Irusen E, Enarson D, Borgdorf M, Beyers N: Comparison of symptoms and treatment outcomes between actively and passively detected tuberculosis cases: the additional value of active case finding. Epidemiol Infect 2008, 136:1342-1349.
• [5]Golub JE, Mohan CI, Comstock GW, Chaisson RE: Active case finding of tuberculosis: historical perspective and future prospects. Int J Tuberc Lung Dis 2005, 9(11):1183-1203.
• [6]UNAIDS: UNAIDS report on the global AIDS epidemic. Geneva, Switzerland: UNAIDS; 2010.
• [7]Hermans S, van Leth F, Manabe Y, Hoepelman A, Lange J, Kambugu A: Earlier initiation of antiretroviral therapy, increased tuberculosis case finding and reduced mortality in a setting of improved HIV care: a retrospective cohort study. HIV Med 2012, 13(6):337-344.
• [8]Hermans SM, Castelnuovo B, Katabira C, Mbidde P, Lange JM, Hoepelman AI, Coutinho A, Manabe YC: Integration of HIV and TB services results in improved TB treatment outcomes and earlier, prioritized ART initiation in a large urban HIV clinic in Uganda. J Acquir Immune Defic Syndr 2012, 60(2):e29-e35.
• [9]Uganda Ministry of Health: National antiretroviral treatment and care guidelines for adults, adolescents, and children. 2009. Available at: http://www.who.int/hiv/amds/uganda_moh_treatment_guidelines.pdf webcite. Accessed January 19, 2009.
• [10]Uganda Ministry of Health: Manual of the National Tuberculosis and Leprosy Programme. 2010.
• [11]Kranzer K, Houben RMGJ, Glynn JR, Bekker L-G, Wood R, Lawn SD: Yield of HIV-associated tuberculosis during intensified case finding in resource-limited settings: a systematic review and meta-analysis. Lancet Infect Dis 2010, 10(2):93-102.
• [12]Getahun H, Kittikraisak W, Heilig CM, Corbett EL, Ayles H, Cain KP, Grant AD, Churchyard GJ, Kimerling M, Shah S, et al.: Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studies. PLoS Med 2011, 8(1):e1000391.
• [13]Moore D, Liechty C, Ekwaru P, Were W, Mwima G, Solberg P, Rutherford G, Mermin J: Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda. AIDS 2007, 21(6):713-719.
• [14]Were W, Moore D, Ekwaru P, Mwima G, Bunnell R, Kaharuza F, Rutherford G, Mermin J: A simple screening tool for active tuberculosis in HIV-infected adults receiving antiretroviral treatment in Uganda. Int J Tuberc Lung Dis 2009, 13(1):47-53.
• [15]Nakanjako D, Mayanja-Kizza H, Ouma J, Wanyenze R, Mwesigire D, Namale A, Ssempiira J, Senkusu J, Colebunders R, Kamya MR: Tuberculosis and human immunodeficiency virus co-infections and their predictors at a hospital-based HIV/AIDS clinic in Uganda. Int J Tuberc Lung Dis 2010, 14(12):1621-1628.
• [16]Albert H, Manabe Y, Lukyamuzi G, Ademun P, Mukkada S, Nyesiga B, Joloba M, Paramasivan CN, Perkins MD: Performance of three LED-based fluorescence microscopy systems for detection of tuberculosis in Uganda. PLoS One 2010, 5(12):e15206.
• [17]Oni T, Burke R, Tsekela R, Bangani N, Seldon R, Gideon HP, Wood K, Wilkinson KA, Ottenhoff TH, Wilkinson RJ: High prevalence of subclinical tuberculosis in HIV-1-infected persons without advanced immunodeficiency: implications for TB screening. Thorax 2011, 66(8):669-673.
• [18]Elden S, Lawes T, Kudsk-Iversen S, Vandelanotte J, Nkawanyana S, Welfare W, Walley J, Wright J: Integrating intensified case finding of tuberculosis into HIV care: an evaluation from rural Swaziland. BMC Health Serv Res 2011, 11(1):118. BioMed Central Full Text
• [19]Steingart KR, Henry M, Ng V, Hopewell PC, Ramsay A, Cunningham J, Urbanczik R, Perkins M, Aziz MA, Pai M: Fluorescence versus conventional sputum smear microscopy for tuberculosis: a systematic review. Lancet Infect Dis 2006, 6(9):570-581.